{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NYSE/VNRX",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# VOLITIONRX LTD (NYSE: VNRX) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is VOLITIONRX LTD, listed on NYSE under ticker VNRX. The ISIN is not on the record, and the LEI is not on the record. The security type is Corporate, the sector is 2835 In Vitro & In Vivo Diagnostic Substances, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 98 filings in the twelve months to 2026-11-08, across 54 filing days. The median gap between filing days is 4 days. The latest filing is dated 2026-10-27, is of type corporate_news, and is 12 days before the record date. The NYSE median cadence gap is 6.0 days, the NYSE median latency is 4.0 days, and the NYSE median filings count is 64.0. The sector median cadence gap is 6.5 days, the sector median latency is 4 days, and the sector median filings count is 61. The issuer's filings are 98, above the NYSE median of 64.0 and above the sector median of 61. The issuer's cadence gap of 4 days is below the NYSE median of 6.0 days and below the sector median of 6.5 days.\n\n## Auditor\n\nThe auditor of record is Sadler, Gibb & Associates, LLC, located in Draper, UT. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe record finds five research houses named on the issuer's investor-relations page: The Benchmark Company, LLC; Jones Research; Zacks; Freedom Capital Markets; and H.C. Wainwright.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://data.sec.gov/submissions/CIK0000093314.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NYSE/VNRX (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/93314/000147793226001832/vnrx_10k.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://ir.volition.com/stock-data/analyst-coverage (coverage)\n- https://mcp.us-cm-kg.ai/record/NYSE/VNRX (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/93314/000147793226001832/vnrx_10k.htm",
    "state": "sourced",
    "value": "Sadler, Gibb & Associates, LLC"
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/93314/000147793226001832/vnrx_10k.htm",
    "state": "sourced",
    "value": "3627"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/93314/000147793226001832/vnrx_10k.htm",
    "state": "sourced",
    "value": "Draper, UT"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NYSE/VNRX",
  "coverage": {
   "count": 5,
   "houses": [
    {
     "analyst": "Bruce Jackson",
     "house": "The Benchmark Company, LLC",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.volition.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Justin Walsh, PhD",
     "house": "Jones Research",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.volition.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Steven Ralston CFA",
     "house": "Zacks",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.volition.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Ilya Zubkov",
     "house": "Freedom Capital Markets",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.volition.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Yi Chen, Ph.D. CFA",
     "house": "H.C. Wainwright",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.volition.com/stock-data/analyst-coverage",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://ir.volition.com/stock-data/analyst-coverage",
     "result": "read: 5 of 10 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 3256,
     "median_cadence_gap_days": 6,
     "median_filings": 64,
     "median_latency_days": 4,
     "name": "NYSE"
    },
    "sector": {
     "issuers": 19,
     "median_cadence_gap_days": 6.5,
     "median_filings": 61,
     "median_latency_days": 4,
     "name": "2835 In Vitro & In Vivo Diagnostic Substances"
    }
   },
   "by_type": {
    "ad_hoc": 8,
    "agm_egm": 6,
    "corporate_news": 9,
    "director_change": 2,
    "directors_dealings": 41,
    "halt_suspension": 2,
    "prospectus": 7,
    "regulatory_filing": 14,
    "results": 9
   },
   "cadence_median_gap_days": 4,
   "filing_days": 54,
   "filings": 98,
   "latency_days": 12,
   "latest": [
    {
     "category": "8-K",
     "date": "2026-10-27",
     "source": "https://www.sec.gov/Archives/edgar/data/93314/000147793226006470/vnrx_8k.htm",
     "title": "8-K — FORM 8-K (items 1.01,8.01,9.01)",
     "type": "corporate_news"
    },
    {
     "category": "4",
     "date": "2026-10-23",
     "source": "https://www.sec.gov/Archives/edgar/data/93314/000147793226006439/xslF345X06/form4.xml",
     "title": "4 — FORM 4",
     "type": "directors_dealings"
    },
    {
     "category": "4",
     "date": "2026-09-30",
     "source": "https://www.sec.gov/Archives/edgar/data/93314/000147793226005936/xslF345X06/form4.xml",
     "title": "4 — FORM 4",
     "type": "directors_dealings"
    },
    {
     "category": "4",
     "date": "2026-09-30",
     "source": "https://www.sec.gov/Archives/edgar/data/93314/000147793226005935/xslF345X06/form4.xml",
     "title": "4 — FORM 4",
     "type": "directors_dealings"
    },
    {
     "category": "8-K",
     "date": "2026-09-25",
     "source": "https://www.sec.gov/Archives/edgar/data/93314/000147793226005804/vnrx_8k.htm",
     "title": "8-K — FORM 8-K (items 3.02)",
     "type": "ad_hoc"
    }
   ],
   "latest_filing_date": "2026-10-27",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NYSE/VNRX",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NYSE"
   },
   "isin": {
    "market": "US",
    "reason": "no LEI, so no GLEIF ISIN route; EDGAR carries no ISIN",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0000093314.json",
    "state": "sourced",
    "value": "United States — Delaware"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-DE",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0000093314.json",
    "state": "sourced",
    "value": "VOLITIONRX LTD"
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0000093314.json",
    "state": "sourced",
    "value": "2835 In Vitro & In Vivo Diagnostic Substances"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0000093314.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "VNRX"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:8d2a6775e4ddf91e0fb461eb95449a183384feeeafa7dfc0f9bdba19f8b68eec",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NYSE/VNRX",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:8d2a6775e4ddf91e0fb461eb95449a183384feeeafa7dfc0f9bdba19f8b68eec",
 "path": "/us/NYSE/VNRX",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is VOLITIONRX LTD, listed on NYSE under ticker VNRX. The ISIN is not on the record, and the LEI is not on the record. The security type is Corporate, the sector is 2835 In Vitro & In Vivo Diagnostic Substances, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 98 filings in the twelve months to 2026-11-08, across 54 filing days. The median gap between filing days is 4 days. The latest filing is dated 2026-10-27, is of type corporate_news, and is 12 days before the record date. The NYSE median cadence gap is 6.0 days, the NYSE median latency is 4.0 days, and the NYSE median filings count is 64.0. The sector median cadence gap is 6.5 days, the sector median latency is 4 days, and the sector median filings count is 61. The issuer's filings are 98, above the NYSE median of 64.0 and above the sector median of 61. The issuer's cadence gap of 4 days is below the NYSE median of 6.0 days and below the sector median of 6.5 days.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is Sadler, Gibb & Associates, LLC, located in Draper, UT. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The record finds five research houses named on the issuer's investor-relations page: The Benchmark Company, LLC; Jones Research; Zacks; Freedom Capital Markets; and H.C. Wainwright.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0000093314.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NYSE/VNRX"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/93314/000147793226001832/vnrx_10k.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://ir.volition.com/stock-data/analyst-coverage"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NYSE/VNRX"
  }
 ],
 "title": "VOLITIONRX LTD (VNRX) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}